Association of IL-10 and TNF-α polymorphisms with risk and aggressiveness of hepatocellular carcinoma in patients with HCV-related cirrhosis

Springer Science and Business Media LLC - 2020
Ahmed Saleh1, Ahmed M Saed1, M. Mansour2
1Department of Internal Medicine, Hepatology & Gastroenterology unit, Faculty of Medicine, Mansoura University, Mansoura, Egypt
2Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt

Tóm tắt

Abstract Background Hepatitis C virus (HCV) infection is a significant risk factor for cirrhosis and hepatocellular carcinoma (HCC) that carry a high mortality. The study aims to investigate the effect of tumour necrosis factor (TNF)-α and interleukin (IL)-10 polymorphisms on risk and pattern of HCC in patients with HCV-related cirrhosis. Results The mean age of the HCC group was 56.21 ± 4.62 years and 54.27 ± 7.63 years for the cirrhotic group. The GG genotype of TNF-ɑ and TT genotype of IL-10 showed a higher incidence of HCC in comparison to the cirrhotic group with P = 0.01 and 0.004. On the calculation of the aggressiveness index (AgI), the TT haplotype was significantly associated with more aggressive tumours in contrast to the other haplotypes with P < 0.001. There is a significant association of portal vein thrombosis, ascites and high AgI with the GG haplotype in contrast to the other haplotypes with P = 0.002, 0.029 and < 0.001, respectively, as regards TNF-α. High AgI (C) was associated with the TT haplotype of IL-10 and GG haplotype of TNF-ɑ. Conclusion Our data bring an essential association of IL-10 and TNF polymorphism with the occurrence of HCC in patients with HCV-related liver cirrhosis. The GG haplotype of TNF-ɑ and TT/AT haplotype of IL-10 are associated with the more aggressive pattern of HCC, so those patients must be treated as early as possible.

Từ khóa


Tài liệu tham khảo

Averhoff FM, Glass N, Holtzman D (2012) Global burden of hepatitis C: considerations for health-care providers in the United States. Clin Infect Dis 55(S1):S10–S15

Waly Raphael S, Yangde Z, Yuxiang C (2012) Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol :421673.

Yang JD, Roberts LR (2010) Epidemiology and management of hepatocellular carcinoma. Infect Dis Clin N Am 24(4):899–919

Yoshimura A (2006) Signal transduction of inflammatory cytokines and tumour development. Cancer Sci 97:439–447

Carr BI, Guerra V (2016) A hepatocellular carcinoma aggressiveness index and its relationship to liver enzyme levels. Oncology 90:215–220

Aroucha DC, Carmo RF, Vasconcelos LR et al (2016) TNF-α and IL-10 polymorphisms increase the risk to hepatocellular carcinoma in HCV infected individuals. J Med Virol 88:1587–1595

Ventura N, Carr BI, Kori I, Guerra V, Shibolet O (2018) Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization. World J Gastroenterol 24(15):1641–1649

EASL-EORTC clinical practice guidelines (2012) management of hepatocellular carcinoma. J Hepatol 56:908–943

Shire NJ, Sherman KE (2015) Epidemiology of hepatitis C virus: a battle on new frontiers. Gastroenterol Clin N Am 44(699):716

National Comprehensive Cancer Network: NCCN clinical practice guidelines in oncology. Hepatobiliary Cancers. Version 3. 2017.

Westbrook RH, Dusheiko G (2014) Natural history of hepatitis C. J Hepatol 61:S58–S68

Seyda Seydel G, Kucukoglu O, Altinbasv A, Demir OO, Yilmaz S, Akkiz H, Otan E, Sowa JP, Canbay A (2016) Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries. Ann Hepatol 15:662–672

Wei Y et al (2011) Polymorphisms of tumour necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis. Dig DisSci 56:2227–2236

Cheng K et al (2013) Tumour necrosis factor-alpha 238G/A polymorphism and risk of hepatocellular carcinoma: evidence from a meta-analysis. Asian Pac J Cancer Prev 14:3275–3279

Zhou P et al (2011) The TNF-alpha-238 polymorphism and cancer risk: ameta- analysis. PLoS One 6:e22092

Swiatek BJ (2012) Is interleukin-10 gene polymorphism a predictive marker in HCV infection? Cytokine Growth Factor Rev 23:47–59

Talaat RM, Esmail AA, Elwakil R, Gurgis AA, Nasr MI (2012) Tumour necrosis factor-alpha _308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients. Chin J Cancer 31:29–35

Radwan MI, Pasha HF, Mohamed RH, Hussien HI, El-Khshab MN (2012) Influence of transforming growth factor-b1 and tumour necrosis factor-ɑ genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients. Cytokine 60:271–276

Baghel K, Srivastava RN, Chandra A, Goel SK, Agrawal J, Kazmi HR, Raj S (2014) TNF-a, IL-6, and IL-8 cytokines and their association with TNF-ɑ -308 G/A polymorphism and postoperative sepsis. J Gastrointest Surg 18:1486–1494

Karimi M, Goldie LC, Cruickshank MN, Moses EK, Abraham LJ (2009) A critical assessment of the factors affecting reporter gene assays for promoter SNP function: a reassessment of -308 TNF polymorphism function using a novel integrated reporter system. Eur J Hum Genet 17:1454–1462

Vikram NK, Bhatt SP, Bhushan B, Luthra K, Misra A, Poddar PK, Pandey RM, Guleria R (2011) Associations of -308G/A polymorphism of tumor necrosis factor (TNF)-ɑ gene and serum TNF-ɑ levels with measures of obesity, intra-abdominal and subcutaneous abdominal fat, subclinical inflammation and insulin resistance in Asian Indians in north India. Dis Markers 31:39–46

Morsi MI et al (2006) Evaluation of tumour necrosis factor-alpha, soluble P-selectin, gamma-glutamyl transferase, glutathioneS-transferase-p and alpha fetoprotein in patients with hepatocellular carcinoma before and during chemotherapy. Br J Biomed Sci 63:74–78

Wang YY et al (2003) Increased serum concentrations of tumour necrosis factor-alpha are associated with disease progression and malnutrition in hepatocellular carcinoma. J Chin Med Assoc 66:593–598

Schmidt-Arras D, Rose-John S (2016) IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol 64:1403–1415

Bouzgarrou N, Hassen E, Farhat K, Bahri O, Gabbouj S, Maamouri N, Ben Mami N, Saffar H, Trabelsi A, Triki H, Chouchane L (2009) Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity. Hum Immunol 70:230–236

Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả